Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?

Core Viewpoint - Labcorp Holdings has shown mixed performance in its recent earnings report, with adjusted earnings per share exceeding estimates but revenues falling short, leading to a decline in share price over the past month [1][4]. Financial Performance - Labcorp reported Q4 2025 adjusted earnings per share of $4.07, beating the Zacks Consensus Estimate by 3% and reflecting an 18% increase year-over-year [2]. - Full-year adjusted earnings per share reached $16.44, a 12.8% increase from the previous year, also surpassing the Zacks Consensus Estimate by 0.8% [3]. Revenue Analysis - Q4 revenues increased by 5.7% year-over-year to $3.52 billion, although this figure missed the Zacks Consensus Estimate by 1% [4]. - Full-year revenues rose 7.2% year-over-year to $13.95 billion, again falling short of the Zacks Consensus Estimate by 0.3% [4]. Segment Performance - Diagnostics Laboratories generated revenues of $2.73 billion in Q4, marking a 5.5% improvement year-over-year [5]. - Biopharma Laboratory Services revenues increased by 3.4% to $793 million, driven by organic growth of 0.6% and a foreign currency translation gain of 2.8% [6]. Margin Performance - Gross margin expanded by 133 basis points to 28.2% in Q4, despite a 3.7% rise in the cost of revenues [7]. - Adjusted operating income improved by 51% year-over-year to $454.6 million, with the adjusted operating margin expanding by 389 basis points to 12.9% due to a 9.5% decline in SG&A expenses [7]. Cash Position - At the end of Q4, Labcorp had cash and cash equivalents of $532.3 million, down from $1.52 billion a year ago, while long-term debt remained stable at $5.08 billion [8]. Guidance for 2026 - Labcorp expects total revenues for 2026 to be in the range of $14.61 billion to $14.79 billion, indicating growth of 4.7% to 6% [9]. - Adjusted earnings per share for 2026 are projected to be between $17.55 and $18.25, with the Zacks Consensus Estimate at $17.62 [10]. Estimate Trends - Recent estimates for Labcorp have shown a downward trend, indicating a potential shift in investor sentiment [11]. VGM Scores - Labcorp currently holds a strong Growth Score of A, with a B in Momentum and Value, placing it in the top 40% for value investors [12]. Outlook - The overall trend in estimates has been downward, and Labcorp holds a Zacks Rank 3 (Hold), suggesting an expectation of an in-line return in the coming months [13].